nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—Henoch-Schonlein purpura—Hydrochlorothiazide—nephrolithiasis	0.101	0.121	CcSEcCtD
Trimethoprim—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0338	0.0407	CcSEcCtD
Trimethoprim—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0298	0.0358	CcSEcCtD
Trimethoprim—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.026	0.0312	CcSEcCtD
Trimethoprim—CYP2C9—urine—nephrolithiasis	0.0255	0.152	CbGeAlD
Trimethoprim—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0224	0.027	CcSEcCtD
Trimethoprim—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0222	0.0267	CcSEcCtD
Trimethoprim—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0214	0.0258	CcSEcCtD
Trimethoprim—CYP3A4—urine—nephrolithiasis	0.0195	0.116	CbGeAlD
Trimethoprim—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0227	CcSEcCtD
Trimethoprim—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0223	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0221	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0211	CcSEcCtD
Trimethoprim—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0209	CcSEcCtD
Trimethoprim—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0207	CcSEcCtD
Trimethoprim—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0166	0.02	CcSEcCtD
Trimethoprim—TYMS—nephron tubule—nephrolithiasis	0.0158	0.0939	CbGeAlD
Trimethoprim—DHFR—nephron tubule—nephrolithiasis	0.0156	0.0929	CbGeAlD
Trimethoprim—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0187	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0179	CcSEcCtD
Trimethoprim—DHFR—renal system—nephrolithiasis	0.0142	0.0845	CbGeAlD
Trimethoprim—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0169	CcSEcCtD
Trimethoprim—DHFR—kidney—nephrolithiasis	0.0137	0.0817	CbGeAlD
Trimethoprim—TYMS—cortex of kidney—nephrolithiasis	0.0135	0.0803	CbGeAlD
Trimethoprim—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0161	CcSEcCtD
Trimethoprim—DHFR—cortex of kidney—nephrolithiasis	0.0133	0.0795	CbGeAlD
Trimethoprim—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0157	CcSEcCtD
Trimethoprim—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0154	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0152	CcSEcCtD
Trimethoprim—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0151	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0151	CcSEcCtD
Trimethoprim—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0146	CcSEcCtD
Trimethoprim—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0145	CcSEcCtD
Trimethoprim—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0143	CcSEcCtD
Trimethoprim—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0108	0.013	CcSEcCtD
Trimethoprim—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0129	CcSEcCtD
Trimethoprim—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00999	0.012	CcSEcCtD
Trimethoprim—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0112	CcSEcCtD
Trimethoprim—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00918	0.011	CcSEcCtD
Trimethoprim—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00912	0.011	CcSEcCtD
Trimethoprim—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00897	0.0108	CcSEcCtD
Trimethoprim—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00896	0.0108	CcSEcCtD
Trimethoprim—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00894	0.0107	CcSEcCtD
Trimethoprim—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00878	0.0105	CcSEcCtD
Trimethoprim—Cough—Hydrochlorothiazide—nephrolithiasis	0.00871	0.0105	CcSEcCtD
Trimethoprim—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0102	CcSEcCtD
Trimethoprim—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0102	CcSEcCtD
Trimethoprim—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00847	0.0102	CcSEcCtD
Trimethoprim—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00822	0.00988	CcSEcCtD
Trimethoprim—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00815	0.00979	CcSEcCtD
Trimethoprim—Shock—Hydrochlorothiazide—nephrolithiasis	0.00802	0.00964	CcSEcCtD
Trimethoprim—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00798	0.00959	CcSEcCtD
Trimethoprim—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00777	0.00934	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00743	0.00892	CcSEcCtD
Trimethoprim—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00737	0.00886	CcSEcCtD
Trimethoprim—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00873	CcSEcCtD
Trimethoprim—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00717	0.00862	CcSEcCtD
Trimethoprim—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00708	0.00851	CcSEcCtD
Trimethoprim—CYP2C8—renal system—nephrolithiasis	0.00704	0.0419	CbGeAlD
Trimethoprim—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00837	CcSEcCtD
Trimethoprim—CYP2C8—kidney—nephrolithiasis	0.0068	0.0405	CbGeAlD
Trimethoprim—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00807	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00801	CcSEcCtD
Trimethoprim—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00778	CcSEcCtD
Trimethoprim—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00774	CcSEcCtD
Trimethoprim—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00774	CcSEcCtD
Trimethoprim—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.006	0.00722	CcSEcCtD
Trimethoprim—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00693	CcSEcCtD
Trimethoprim—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00558	0.0067	CcSEcCtD
Trimethoprim—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00539	0.00648	CcSEcCtD
Trimethoprim—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00623	CcSEcCtD
Trimethoprim—Rash—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00618	CcSEcCtD
Trimethoprim—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00617	CcSEcCtD
Trimethoprim—Headache—Hydrochlorothiazide—nephrolithiasis	0.00511	0.00614	CcSEcCtD
Trimethoprim—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00582	CcSEcCtD
Trimethoprim—CYP3A4—renal system—nephrolithiasis	0.00477	0.0284	CbGeAlD
Trimethoprim—CYP3A4—kidney—nephrolithiasis	0.00461	0.0275	CbGeAlD
Trimethoprim—ABCB1—nephron tubule—nephrolithiasis	0.00371	0.0221	CbGeAlD
Trimethoprim—ABCB1—renal system—nephrolithiasis	0.00337	0.0201	CbGeAlD
Trimethoprim—ABCB1—kidney—nephrolithiasis	0.00326	0.0194	CbGeAlD
Trimethoprim—ABCB1—cortex of kidney—nephrolithiasis	0.00318	0.0189	CbGeAlD
